![](/img/cover-not-exists.png)
PO-55 - Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors – a way to improve personalized cancer therapy?
Deb, S., Sjöström, C., Tharmakulanathan, A., Boknäs, N., Lotfi, K., Ramström, S.Volume:
140
Language:
english
Journal:
Thrombosis Research
DOI:
10.1016/s0049-3848(16)30188-8
Date:
April, 2016
File:
PDF, 410 KB
english, 2016